CELESIA, Adriana
 Distribuzione geografica
Continente #
NA - Nord America 369
EU - Europa 311
AS - Asia 61
SA - Sud America 11
AF - Africa 4
OC - Oceania 3
Totale 759
Nazione #
US - Stati Uniti d'America 368
IT - Italia 235
SG - Singapore 21
DE - Germania 20
IE - Irlanda 13
BR - Brasile 11
GB - Regno Unito 11
TR - Turchia 9
CN - Cina 6
IN - India 6
ES - Italia 5
FI - Finlandia 5
HK - Hong Kong 5
KR - Corea 5
RO - Romania 5
BG - Bulgaria 4
IR - Iran 4
SE - Svezia 3
BE - Belgio 2
CI - Costa d'Avorio 2
FR - Francia 2
NL - Olanda 2
NZ - Nuova Zelanda 2
AU - Australia 1
AZ - Azerbaigian 1
CA - Canada 1
EG - Egitto 1
KG - Kirghizistan 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
RU - Federazione Russa 1
UA - Ucraina 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 759
Città #
Chandler 79
Palermo 66
Ashburn 51
Fairfield 23
New York 20
Medford 17
Singapore 17
Rome 16
Verona 13
Princeton 11
Santa Clara 11
Dublin 10
Mistretta 9
Woodbridge 9
Ann Arbor 7
Cambridge 7
Chions 7
Istanbul 7
Cascina 6
Catanzaro 6
Lawrence 6
Milan 5
Naples 5
Rio de Janeiro 5
Seattle 5
Venice 5
Wilmington 5
Altamura 4
Arcole 4
Belfast 4
Bremen 4
Cagliari 4
Central 4
Chennai 4
Helsinki 4
Houston 4
London 4
Ludwigshafen am Rhein 4
Sao Pedro da Aldeia 4
Sofia 4
Alcamo 3
Camerino 3
Cinisello Balsamo 3
Des Moines 3
Madrid 3
Montereale Valcellina 3
New Castle 3
Năsăud 3
Sandston 3
Tehran 3
Aachen 2
Abidjan 2
Alegria 2
Altofonte 2
Amsterdam 2
Auckland 2
Boardman 2
Brussels 2
Dallas 2
Eskişehir 2
Florence 2
Hildesheim 2
Leipzig 2
Lingenfeld 2
Marsala 2
Portland 2
Pune 2
Roverbella 2
Salerno 2
San Biagio Platani 2
San Cesareo 2
San Diego 2
San Giuliano Milanese 2
São Paulo 2
Torre del Lago Puccini 2
Vedano Olona 2
Wuhan 2
Yangcheon-gu 2
Alessandria Della Rocca 1
Bagheria 1
Baku 1
Bani Suwayf 1
Beijing 1
Belgrade 1
Bishkek 1
Changsha 1
Chicago 1
Cleveland 1
College Park 1
Erlangen 1
Foggia 1
Fondi 1
Fort Worth 1
Francavilla Fontana 1
Frankfurt am Main 1
Geumcheon-gu 1
Gimhae 1
Giussano 1
Gumi 1
Hanover 1
Totale 588
Nome #
THE HDAC INHIBITOR ITF2357 (GIVINOSTAT) AS A KEY PLAYER IN EPIGENETIC TARGETING OF MELANOMA AND COLON CANCER CELLS 129
Tributyltin(IV) ferulate, a novel synthetic ferulic acid derivative, induces autophagic cell death in colon cancer cells: From chemical synthesis to biochemical effects 102
Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties 74
ROS-Dependent ER Stress and Autophagy Mediate the Anti-Tumor Effects of Tributyltin (IV) Ferulate in Colon Cancer Cells 69
Anti-adipogenic potential of bio-waste products of Sicilian mango in 3T3-L1 cells 67
Bortezomib potentiates the antitumor effect of tributyltin(IV) ferulate in colon cancer cells exacerbating ER stress and promoting apoptosis 57
Combined treatment of caffeic acid and DMAPT induces AMPK dependent death in MDA-MB231 cells 54
The good and bad of nrf2: An update in cancer and new perspectives in COVID-19 49
The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis 49
Oncogenic BRAF protein as a molecular target of HDAC inhibitors in melanoma cells 48
HDAC inhibitors target oncogenic BRAF and p53 in melanoma cells and promote a switch from pro-survival autophagy to apoptosis 42
Tributyltin(Iv) butyrate: A novel epigenetic modifier with er stress-and apoptosis-inducing properties in colon cancer cells 41
Oxidative stress induced by the novel compound tributyltin(iv) ferulate promotes ER stress and autophagy in colon cancer cells 28
Oncogenic BRAF and p53 Interplay in Melanoma Cells and the Effects of the HDAC Inhibitor ITF2357 (Givinostat) 23
Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells 18
Totale 850
Categoria #
all - tutte 4.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 0 0 0 10 5 6 5
2020/202140 1 4 1 1 9 3 0 2 0 13 0 6
2021/2022140 2 7 11 0 1 2 18 24 21 18 11 25
2022/2023278 28 34 16 28 20 64 8 13 26 3 14 24
2023/2024286 35 31 17 47 17 56 18 16 4 15 9 21
2024/202580 18 37 25 0 0 0 0 0 0 0 0 0
Totale 850